Fracture risk after the diagnosis of Parkinson's disease: Influence of concomitant dementia

Movement Disorders

Volumn 21, Issue 9, 2006, Pages 1361-1367

  Melton III, L Joseph ^a   Leibson, Cynthia L ^a   Achenbach, Sara J ^a   Bower, James H ^a   Maraganore, Demetrius M ^a   Oberg, Ann L ^a   Rocca, Walter A ^a  

^a Mayo Clinic   (United States)

Author keywords

Dementia; Epidemiology; Hip fracture; Osteoporosis; Parkinson's disease

Indexed keywords

ADULT; AGE; AGED; ARM FRACTURE; ARTICLE; CLAVICLE FRACTURE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMENTIA; FACE FRACTURE; FEMALE; FEMUR FRACTURE; FOOT FRACTURE; FRACTURE; HIP FRACTURE; HOSPITAL PATIENT; HUMAN; LEG FRACTURE; MALE; MEDICAL RECORD; OSTEOLYSIS; OUTPATIENT; PARKINSON DISEASE; PELVIS FRACTURE; PREDICTION; PRIORITY JOURNAL; RIB FRACTURE; RISK FACTOR; RISK REDUCTION; SKULL FRACTURE; VERTEBRA FRACTURE;

ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEMENTIA; FEMALE; FRACTURES, BONE; HIP FRACTURES; HUMANS; MALE; MIDDLE AGED; MINNESOTA; OSTEOPOROSIS; PARKINSON DISEASE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STATISTICS;

EID: 33750335000     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20946     Document Type: Article

References (55)

1. Johnell O, Melton LJ III, Atkinson EJ, O'Fallon WM, Kurland LT. Fracture risk in patients with parkinsonism: a population-based study in Olmsted County, Minnesota. Age Aging 1992;21:32-38.
2. Johnell O, Sernbo I. Health and social status in patients with hip fractures and controls. Age Ageing 1986;15:285-291.
3. Grisso JA, Kelsey JL, Strom BL, et al., and the Northeast Hip Fracture Study Group. Risk factors for falls as a cause of hip fracture in women. N Engl J Med 1991;324:1326-1331.
4. Mannius S, Mellström D, Lindstedt G, Rundgren Å, Zetterberg C. Health status and risk for hip fracture: a case control study of 70-75-year olds. Arch Gerontol Geriatr 1992;15:151-162.
5. Poór G, Atkinson EJ, O'Fallon WM, Melton LJ III. Predictors of hip fractures in elderly men. J Bone Miner Res 1995;10:1900-1907.
6. Lau EMC, Suriwongpaisal P, Lee JK, et al. Risk factors for hip fracture in Asian men and women: the Asian Osteoporosis Study. J Bone Miner Res 2001;16:572-580.
7. Pressley JC, Louis ED, Tang M-X, et al. The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology 2003;60:87-93.
8. Taylor BC, Schreiner PJ, Stone KL, et al. Long-term prediction of incident hip fracture risk in elderly white women: Study of Osteoporotic Fractures. J Am Geriatr Soc 2004;52:1479-1486.
9. Leibson CL, Maraganore DM, Bower JH, Ransom JE, O'Brien PC, Rocca WA. Co-morbid conditions associated with Parkinson's disease: a population-based study. Mov Disord 2006;2144,46-455.
10. Emre M. Dementia associated with Parkinson's disease. Lancet Neurol 2003;2:229-237.
11. Buchner DM, Larson EB. Falls and fractures in patients with Alzheimer-type dementia. JAMA 1987;257:1492-1495.
12. Melton LJ III, Beard CM, Kokmen E, Atkinson EJ, O'Fallon WM. Fracture risk in patients with Alzheimer's disease. J Am Geriatr Soc 1994;42:614-619.
13. Johnell O, Gullberg B, Kanis JA, et al. Risk factors for hip fracture in European women: the MEDOS Study. J Bone Miner Res 1995; 10:1802-1815.
14. Johansson C, Skoog I. A population-based study on the association between dementia and hip fractures in 85-year olds. Aging Clin Exp Res 1996;8:189-196.
15. Kanis J, Johnell O, Gullberg B, et al. Risk factors for hip fracture in men from Southern Europe: the MEDOS Study. Osteoporos Int 1999;9:45-54.
16. Weller I, Schatzker J. Hip fractures and Alzheimer's disease in elderly institutionalized Canadians. Ann Epidemiol 2004;14:319-324.
17. Porter RW, Miller CG, Grainger D, Palmer SB. Prediction of hip fracture in elderly women: a prospective study. Br Med J 1990; 301:638-641.
18. Hughes TA, Ross HF, Musa S, et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease. Neurology 2000;54:1596-1602.
19. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996;71:266-274.
20. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology 1999;52:1214-1220.
21. Elbaz A, Peterson BJ, Yang P, et al. Nonfatal cancer preceding Parkinson's disease: a case-control study. Epidemiology 2002;13: 157-164.
22. Melton LJ III. The threat to medical-records research. N Engl J Med 1997;337:1466-1470.
23. Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ III. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res 1992;7: 221-227.
24. Edland SD, Rocca WA, Petersen RC, Cha RH, Kokmen E. Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn. Arch Neurol 2002;59:1589-1593.
25. Knopman DS, Rocca WA, Cha RH, Edland SD, Kokmen E. Incidence of vascular dementia in Rochester, Minn, 1985-1989. Arch Neurol 2002;59:1605-1610.
26. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM IV). Arlington, VA: American Psychiatric Association; 1994.
27. Cummings SR, Melton LJ III. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002;359:1761-1767.
28. Themeau TM, Grambsch PM. Modeling survival data: extending the Cox Model. New York: Springer-Verlag; 2000. p 1-350.
29. Kom EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 1997;145:72-80.
30. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
31. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley and Sons; 1980. p 1-321.
32. Melton LJ III, Patel A, Achenbach SJ, Oberg AL, Yunginger JW. Long-term fracture risk among children with asthma: a population-based study. J Bone Miner Res 2005;20:564-570.
33. Cox DR. Some simple approximate tests for Poisson variates. Biometrika 1953;40:354-360.
34. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-619.
35. Leibson CL, Tosteson ANA, Gabriel SE, Ransom JE, Melton LJ III. Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study. J Am Geriatr Soc 2002;50:1644-1650.
36. Bloem BR, Steijns JAG, Smits-Engelsman BC. An update on falls. Curr Opin Neurol 2003;16:15-26.
37. Greenspan SL, Myers ER, Maitland LA, Resnick NM, Hayes WC. Fall severity and bone mineral density as risk factors for hip fracture in ambulatory elderly. JAMA 1994;271:128-133.
38. Grimbergen YAM, Munneke M, Bloem BR. Falls in Parkinson's disease. Curr Opin Neurol 2004;17:405-415.
39. Ishizaki F, Harada T, Katayama S, Abe H, Nakamura S. Relationship between osteopenia and clinical characteristics of Parkinson's disease. Mov Disord 1993;8:507-511.
40. Kao, CH, Chen CC, Wang SJ, Chia LG, Yeh SH. Bone mineral density in patients with Parkinson's disease measured by dual photon absorptiometry. Nucl Med Commun 1994;15:173-177.
41. Taggart H, Crawford V. Reduced bone density of the hip in elderly patients with Parkinson's disease. Age Ageing 1995;24:326-328.
42. Revilla M, de la Sierra G, Aguado F, Varela L, Jimenez-Jimenez FJ, Rico H. Bone mass in Parkinson's disease: a study with three methods. Calcif Tissue Int 1996;58:311-315.
43. Sato Y, Kikuyama M, Oizumi K. High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease. Neurology 1997;49:1273-1278.
44. Riggs BL, Khosla S, Melton LJ III. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002;23: 279-302.
45. Benedetti MD, Maraganore DM, Bower JH, et al. Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study. Mov Disord 2001;16:830-837.
46. Rocca WA, Grossardt BR, Bower JH, Ahlskog JE, de Andrade M, Maraganore DM. The Mayo Clinic cohort study of oophorectomy and aging: results for parkinsonism and Parkinson's disease. Neurology 2005;64(Suppl. 1):A273.
47. Bloem BR, van Vugt JPP, Beckley DJ. Postural instability and falls in Parkinson's disease. Adv Neurol 2001;87:209-223.
48. Cizza G, Ravn P, Chrousos GP, Gold PW. Depression: a major, unrecognized risk factor for osteoporosis? Trends Endocrinol Metab 2001;12:198-203.
49. McClung MR, Geusens P, Miller PD, et al. for the Hip Intervention Program Study Group. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001;344:333-340.
50. Elbaz A, Bower JH, Peterson BJ, et al. Survival study of Parkinson disease in Olmsted County, Minnesota. Arch Neurol 2003;60:91-96.
51. Melton LJ III, Crowson CS, O'Fallon WM. Fracture incidence in Olmsted County, Minnesota: comparison of urban with rural rates and changes in urban rates over time. Osteoporos Int 1999;9:29-37.
52. Parashos SA, Maraganore DM, O'Brien PC, Rocca WA. Medical services utilization and prognosis in Parkinson disease: a populationbased study. Mayo Clin Proc 2002;77:918-925.
53. Melton LJ III, Atkinson EJ, Madhok R. Downturn in hip fracture incidence. Public Health Rep 1996;111:146-150.
54. 3 in elderly patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1999; 66:64-68.
55. Sato Y, Honda Y, Kaji M, et al. Amelioration of osteoporosis by menatetrenone in elderly female Parkinson's disease patients with vitamin D deficiency. Bone 2002;31:114-118.